Which numbing drug works best for dialysis access surgery?

NCT ID NCT07259772

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests two numbing medicines, ropivacaine and lidocaine, in 40 adults with end-stage kidney disease who need surgery to create a blood vessel connection (fistula) for dialysis. Patients are randomly assigned to receive one of the two drugs during surgery, and neither they nor their surgeons know which one is used. Researchers measure pain levels, surgery time, need for extra pain relief, and how well the fistula works over the next 5 years. The goal is to find which drug provides better pain control and may improve long-term surgical success.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ARTERIOVENOUS FISTULA PATENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Lianyungang First People's Hospital

    Lianyungang, Jiangsu, 222000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.